Current Oncology Clinical Trials
Although we are making considerable progress in the fight against cancer, we still have a long way to go. Often, the best new information about cancer comes from animals participating in a clinical trial.
If you do not live in our region of the country, you could check with the Veterinary Cancer Society to learn about clinical trials in your area.
Emerging Canine Cancer Studies
We are currently recruiting for Emerging Canine Cancer Studies
- High Intensity Focused Ultrasound (HIFU) for Lymphoma in Dogs
- High Intensity Focused Ultrasound (HIFU) for Osteosarcoma in Dogs
- Immunotherapy Trial of New Cancer Vaccine
Learn more about our Emerging Canine Cancer Studies
Canine Urinary Bladder Cancer
For dogs with urinary bladder cancer (TCC) affecting the bladder and/or urethra. The study is aimed at learning how the dog’s immune system can be stimulated to attack the cancer.
Learn more about our Canine Urinary Bladder Cancer Trial
Canine Osteosarcoma
The WCORC and Purdue Institute for Cancer Research have recently launched a research program in canine osteosarcoma to identify new, effective therapies in dogs that will improve cure rates for both dogs and humans with this cancer.
Our current focus is on collecting tumor tissues from dogs undergoing amputation to analyze them for susceptibility to novel drugs. A financial incentive of $500 per dog is available to help offset the cost of amputation to the owners of dogs contributing to this research.
We are excited to announce a new clinical trial for osteosarcoma that studies the clinical, molecular, and immune characterization of this tumor type. Eligible dogs must have a confirmed diagnosis, no evidence of metastasis, or spread, to other parts of the body, and received no prior treatment.
Tumor Ablation Studies
H-FIRE Liver Cancer Study is evaluating the safety and immune effects of High-Frequency Irreversible Electroporation (H-FIRE) for dogs diagnosed with liver cancer.
The goals of this study are to evaluate the safety and feasibility of H-FIRE in dogs with liver cancer, measure local and systemic immune responses after H-FIRE treatment, analyze tumor biopsies, blood immune cells, and cytokines before and after treatment, and determine whether a single H-FIRE treatment can stimulate a meaningful anti-tumor immune response.
